• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双相障碍的评定量表是否适用?

Are rating scales for bipolar disorders fit for purpose?

机构信息

Professor, Psychological Medicine,Newcastle University,UKandVisiting Professor,Institute of Psychiatry, Psychology and Neuroscience,UKandDepartment of Mental Health,NTNU,Norway and Brain and Mind Centre,The University of Sydney,Australia.

Professor, Clinical Psychology,Centre for Mental Health, Swinburne University of Technology,Australia.

出版信息

Br J Psychiatry. 2018 Nov;213(5):627-629. doi: 10.1192/bjp.2018.189.

DOI:10.1192/bjp.2018.189
PMID:30339112
Abstract

The DSM-5 definition of bipolar disorder elevates increased activity or energy as a cardinal symptom (alongside mood changes) for mania and hypomania ('hypo/mania'). The ICD-10 likewise requires increases in activity and energy (alongside mood) for hypo/mania, as well as decreases for bipolar depression. Using bipolar disorder as an example, we propose that, when diagnostic criteria are revised, instruments used to measure clinical course and treatment response may need revisiting. Here, we highlight that the 'gold-standard' symptom rating scales for hypo/mania and depression were developed in an era when abnormalities of mood were viewed as the cardinal symptom of bipolar disorder. We contend that archetypal measures fail to give proportionate weighting to activity or energy, undermining their utility in monitoring bipolar disorder and treatment response in clinical and research practice.Declarations of interestJ.S. and G.M. are members of mMARCH, (Motor Activity Research Consortium for Health), which is led by Dr Kathleen Merikangas, National Institute for Mental Health. J.S. reports being a visiting professor at Diderot University, the Norwegian University of Science and Technology, Swinburne University of Technology and The University of Sydney; receiving grant funding from the UK Medical Research Council and from the UK Research for Patient Benefit programme; and receiving a personal fee from Janssen-Cilag for a non-promotional talk on sleep problems.

摘要

DSM-5 对双相情感障碍的定义将活动或能量增加作为躁狂症和轻躁狂(“轻躁狂/躁狂”)的主要症状(与情绪变化一起)。ICD-10 同样要求轻躁狂/躁狂时活动和能量增加(与情绪一起),以及双相情感障碍抑郁时减少。以双相情感障碍为例,我们提出,当诊断标准修订时,用于测量临床病程和治疗反应的工具可能需要重新审视。在这里,我们强调,轻躁狂/躁狂和抑郁的“金标准”症状评定量表是在将情绪异常视为双相情感障碍主要症状的时代开发的。我们认为,典型的测量方法没有给活动或能量适当的权重,从而削弱了它们在监测双相情感障碍和治疗反应方面的实用性,无论是在临床实践还是研究实践中。利益声明 J.S. 和 G.M. 是 mMARCH(健康运动研究联盟)的成员,该联盟由美国国立精神卫生研究院的 Kathleen Merikangas 博士领导。J.S. 报告说他是迪德罗大学、挪威科技大学、斯威本科技大学和悉尼大学的客座教授;从英国医学研究理事会和英国患者受益研究计划获得资助;并因有关睡眠问题的非促销演讲从杨森制药公司获得个人费用。

相似文献

1
Are rating scales for bipolar disorders fit for purpose?双相障碍的评定量表是否适用?
Br J Psychiatry. 2018 Nov;213(5):627-629. doi: 10.1192/bjp.2018.189.
2
Bipolar II disorder : epidemiology, diagnosis and management.双相II型障碍:流行病学、诊断与管理
CNS Drugs. 2007;21(9):727-40. doi: 10.2165/00023210-200721090-00003.
3
ECNP consensus meeting. Bipolar depression. Nice, March 2007.欧洲神经精神药理学会共识会议。双相抑郁症。英国尼斯,2007年3月。
Eur Neuropsychopharmacol. 2008 Jul;18(7):535-49. doi: 10.1016/j.euroneuro.2008.03.003. Epub 2008 May 23.
4
Evaluating response to mood stabilizers in patients with mixed depression: A study of agreement between three different mania rating scales and a depression rating scale.评估混合性抑郁症患者对心境稳定剂的反应:一项关于三种不同躁狂评定量表与一种抑郁评定量表之间一致性的研究。
J Affect Disord. 2016 Jun;197:1-7. doi: 10.1016/j.jad.2016.02.064. Epub 2016 Mar 3.
5
Prepubertal and early adolescent bipolar I disorder: review of diagnostic validation by Robins and Guze criteria.青春期前及青少年早期双相I型障碍:依据罗宾斯和古泽标准进行的诊断验证综述
J Clin Psychiatry. 2005;66 Suppl 7:21-8.
6
Bipolar disorders in the new DSM-5 and ICD-11 classifications.双相障碍在新的 DSM-5 和 ICD-11 分类中的表现。
Rev Psiquiatr Salud Ment. 2014 Oct-Dec;7(4):179-85. doi: 10.1016/j.rpsm.2014.07.005.
7
The prevalence and illness characteristics of DSM-5-defined "mixed feature specifier" in adults with major depressive disorder and bipolar disorder: Results from the International Mood Disorders Collaborative Project.《精神疾病诊断与统计手册》第5版定义的“混合特征说明符”在重度抑郁症和双相情感障碍成人患者中的患病率及疾病特征:国际心境障碍协作项目的结果
J Affect Disord. 2015 Feb 1;172:259-64. doi: 10.1016/j.jad.2014.09.026. Epub 2014 Oct 12.
8
Validity and utility of bipolar spectrum models.双相谱模型的有效性和实用性。
Bipolar Disord. 2008 Feb;10(1 Pt 2):179-93. doi: 10.1111/j.1399-5618.2007.00562.x.
9
The AREDOC project and its implications for the definition and measurement of the bipolar disorders: A summary report.AREDOC 项目及其对双相障碍定义和测量的影响:总结报告。
Aust N Z J Psychiatry. 2022 Nov;56(11):1389-1397. doi: 10.1177/00048674221103478. Epub 2022 Jun 10.
10
Determining if Borderline Personality Disorder and Bipolar Disorder Are Alternative Expressions of the Same Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions.确定边缘性人格障碍和双相情感障碍是否为同一疾病的不同表现形式:来自酒精及相关疾病国家流行病学调查的结果。
J Clin Psychiatry. 2017 Sep/Oct;78(8):e994-e999. doi: 10.4088/JCP.16m11190.

引用本文的文献

1
A Systematic Review of the Clinical Use of Gabapentin and Pregabalin in Bipolar Disorder.加巴喷丁和普瑞巴林在双相情感障碍临床应用的系统评价
Pharmaceuticals (Basel). 2021 Aug 24;14(9):834. doi: 10.3390/ph14090834.
2
How Does Adding the DSM-5 Criterion Increased Energy/Activity for Mania Change the Bipolar Landscape?添加《精神疾病诊断与统计手册》第五版(DSM-5)中躁狂发作的精力/活动增加标准如何改变双相情感障碍的格局?
Front Psychiatry. 2021 Feb 18;12:638440. doi: 10.3389/fpsyt.2021.638440. eCollection 2021.
3
Can an Integrated Science Approach to Precision Medicine Research Improve Lithium Treatment in Bipolar Disorders?
精准医学研究的综合科学方法能否改善双相情感障碍的锂盐治疗?
Front Psychiatry. 2018 Aug 21;9:360. doi: 10.3389/fpsyt.2018.00360. eCollection 2018.